133 related articles for article (PubMed ID: 26617970)
1. Discovery of New Acid Ceramidase-Targeted Acyclic 5-Alkynyl and 5-Heteroaryl Uracil Nucleosides.
Meščić A; Harej A; Klobučar M; Glavač D; Cetina M; Pavelić SK; Raić-Malić S
ACS Med Chem Lett; 2015 Nov; 6(11):1150-5. PubMed ID: 26617970
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel 5-substituted acyclic pyrimidine nucleosides as potent and selective inhibitors of hepatitis B virus.
Kumar R; Nath M; Tyrrell DL
J Med Chem; 2002 May; 45(10):2032-40. PubMed ID: 11985471
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
[TBL] [Abstract][Full Text] [Related]
4. Acid ceramidase and its inhibitors: a
Doan NB; Alhajala H; Al-Gizawiy MM; Mueller WM; Rand SD; Connelly JM; Cochran EJ; Chitambar CR; Clark P; Kuo J; Schmainda KM; Mirza SP
Oncotarget; 2017 Dec; 8(68):112662-112674. PubMed ID: 29348854
[TBL] [Abstract][Full Text] [Related]
5. Acid Ceramidase: A Novel Therapeutic Target in Cancer.
Vijayan Y; Lankadasari MB; Harikumar KB
Curr Top Med Chem; 2019; 19(17):1512-1520. PubMed ID: 30827244
[TBL] [Abstract][Full Text] [Related]
6. Histotype-specific analysis of acid ceramidase expression in ovarian cancer.
El-Balat A; Karn T; Holtrich U; Becker S; Kommoss S; Győrffy B; Anglesio MS; Huntsman DG; Drosos Z; Rody A; Gevensleben H; Hanker LC
Virchows Arch; 2020 Jun; 476(6):855-862. PubMed ID: 31897818
[TBL] [Abstract][Full Text] [Related]
7. Novel pyrimidine-2,4-dione-1,2,3-triazole and furo[2,3-d]pyrimidine-2-one-1,2,3-triazole hybrids as potential anti-cancer agents: Synthesis, computational and X-ray analysis and biological evaluation.
Gregorić T; Sedić M; Grbčić P; Tomljenović Paravić A; Kraljević Pavelić S; Cetina M; Vianello R; Raić-Malić S
Eur J Med Chem; 2017 Jan; 125():1247-1267. PubMed ID: 27875779
[TBL] [Abstract][Full Text] [Related]
8. Targeting acid ceramidase enhances antitumor immune response in colorectal cancer.
Vijayan Y; James S; Viswanathan A; Aparna JS; Bindu A; Namitha NN; Anantharaman D; Babu Lankadasari M; Harikumar KB
J Adv Res; 2023 Dec; ():. PubMed ID: 38142035
[TBL] [Abstract][Full Text] [Related]
9. Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and β1 integrin/FAK-mediated signalling.
Klobučar M; Grbčić P; Pavelić SK; Jonjić N; Visentin S; Sedić M
Biochem Biophys Res Commun; 2018 Sep; 503(2):843-848. PubMed ID: 29920241
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of unsaturated keto and exomethylene D-arabinopyranonucleoside analogs: novel 5-fluorouracil analogs that target thymidylate synthase.
Tzioumaki N; Manta S; Tsoukala E; Vande Voorde J; Liekens S; Komiotis D; Balzarini J
Eur J Med Chem; 2011 Apr; 46(4):993-1005. PubMed ID: 21330014
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel uracil non-nucleoside derivatives as potential reverse transcriptase inhibitors of HIV-1.
El-Brollosy NR; Al-Deeb OA; El-Emam AA; Pedersen EB; La Colla P; Collu G; Sanna G; Loddo R
Arch Pharm (Weinheim); 2009 Nov; 342(11):663-70. PubMed ID: 19856332
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral and cytostatic evaluations of the new C-5 substituted pyrimidine and furo[2,3-d]pyrimidine 4',5'-didehydro-L-ascorbic acid derivatives.
Gazivoda T; Sokcević M; Kralj M; Suman L; Pavelić K; De Clercq E; Andrei G; Snoeck R; Balzarini J; Mintas M; Raić-Malić S
J Med Chem; 2007 Aug; 50(17):4105-12. PubMed ID: 17672445
[TBL] [Abstract][Full Text] [Related]
13. The novel C-5 aryl, alkenyl, and alkynyl substituted uracil derivatives of L-ascorbic acid: synthesis, cytostatic, and antiviral activity evaluations.
Gazivoda T; Raić-Malić S; Marjanović M; Kralj M; Pavelić K; Balzarini J; De Clercq E; Mintas M
Bioorg Med Chem; 2007 Jan; 15(2):749-58. PubMed ID: 17092728
[TBL] [Abstract][Full Text] [Related]
14. Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancer.
Ruckhäberle E; Holtrich U; Engels K; Hanker L; Gätje R; Metzler D; Karn T; Kaufmann M; Rody A
Climacteric; 2009 Dec; 12(6):502-13. PubMed ID: 19905902
[TBL] [Abstract][Full Text] [Related]
15. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
16. Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity.
Hattori H; Tanaka M; Fukushima M; Sasaki T; Matsuda A
J Med Chem; 1996 Dec; 39(25):5005-11. PubMed ID: 8960561
[TBL] [Abstract][Full Text] [Related]
17. Antiviral and Cytostatic Evaluation of 5-(1-Halo-2-sulfonylvinyl)- and 5-(2-Furyl)uracil Nucleosides.
Wen Z; Suzol SH; Peng J; Liang Y; Snoeck R; Andrei G; Liekens S; Wnuk SF
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28304114
[TBL] [Abstract][Full Text] [Related]
18. The unsaturated acyclic nucleoside analogues bearing a sterically constrained (Z)-4'-benzamido-2'-butenyl moiety: Synthesis, X-ray crystal structure study, cytostatic and antiviral activity evaluations.
Benci K; Wittine K; Radan M; Cetina M; Sedić M; Kraljević Pavelić S; Pavelić K; Clercq ED; Mintas M
Bioorg Med Chem; 2010 Sep; 18(17):6249-57. PubMed ID: 20696582
[TBL] [Abstract][Full Text] [Related]
19. Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines.
Vethakanraj HS; Babu TA; Sudarsanan GB; Duraisamy PK; Ashok Kumar S
Biochem Biophys Res Commun; 2015 Aug; 464(3):833-9. PubMed ID: 26188095
[TBL] [Abstract][Full Text] [Related]
20. New medium oxacyclic O,N-acetals and related open analogues: biological activities.
Campos J; Saniger E; Marchal JA; Aiello S; Súarez I; Boulaiz H; Aránega A; A Gallo M; Espinosa A
Curr Med Chem; 2005; 12(12):1423-38. PubMed ID: 15974993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
